According to a new market report published by Transparency Market Research
“Synthetic Biology Market, Global Industry Analysis, Size, Growth, Share and
Forecast, 2012 – 2018″, global Synthetic biology market was worth USD 1,537.5
million in 2011. The market grew to a value of USD 2,120 million in 2012, and
is expected to reach USD 16,745 million by 2018, growing at a CAGR of 41.1%
from 2010 to 2018. In the overall global market, Europe holds the maximum
market share, and is expected to maintain its lead position in terms of revenue
The global Synthetic biology market is driven by factors such as increasing incidence of oceanic oil spills and other types of pollutions, potential substitute of genetic engineering, increasing demand for cross bred animals, dropping prices of DNA sequencing and DNA synthesis, increasing population is increasing the demand for GM (Genetically Modified) food, increasing demand for alternative energy resources like biofuels, and rising R&D investments in drug development.
Some of the opportunities in the synthetic biology market which would drive the
revenue of the industry in the future include rising economies of Asia Pacific
regions and the BRICS nations, and increasing investments of WHO and other NGOs
in third world countries to fight epidemic diseases such as malaria.
Europe holds the maximum market share in the synthetic biology market, owing to
high demand of synthetic biology products like biofuels and increasing R&D
activities in the field of synthetic biology. The Europe synthetic biology
market was valued at USD 619.5 million in the year 2011, and is expected to
grow at a CAGR of 39.8% from 2012 to 2018, to reach USD 6,389.5 million by the
The synthetic biology market can be segmented into 4 major categories:
synthetic biology market by products, synthetic biology market by enabled
product application, synthetic biology technology by enabling technology and
synthetic biology by geography. The global synthetic biology market by enabling
technology was valued at USD 183.84 million and is expected to grow at a CAGR
of 44.7% from 2012 to 2018, to reach an estimated value of USD 1780.40 million
Some of the key market players in the synthetic biology market are NEB, Amyris
Biotechnology Inc, Blue Heron Biotechnology Inc, Chromatin, Febit Symbio GmbH,
Gene Art-Life Science Technologies, Synthetic Genomics, Verdezyne Inc, New
England Biolabs Inc, and others.
This research is specially designed to estimate and analyze the demand and
performance of synthetic biology products in global scenario. This research
provides in-depth analysis of Synthetic biology product manufacturers, product
sales, trend analysis by segments and demand by geography.
The report covers all the major product segments of the global Synthetic biology market and provides in-depth analysis, historical data and statistically refined forecast for the segments covered. The study presents a comprehensive assessment of the stakeholder strategies and winning imperatives for them by segmenting the global Synthetic biology market as below:
Biology Market by Products
• Enabling Products
Synthetic Biology Enabled Products by Application
• Chemicals and Energy Market
• Diagnostics and Pharmaceutical Market
• Biofuels Market
Synthetic Biology Market by Enabling Technologies
• Synthetic Biology Enabling Technology
• Synthetic Biology Enabling Technologies, Market Overview
• DNA Sequencing Technologies
• Bioinformatics Technologies
• Biological Components and Integrated Systems Applications
• Genome Engineering
In addition the report provides a cross-sectional analysis of all the above segments with respect to the North America, Europe and Asia Pacific regions.The in-depth research and high level analysis will allow synthetic biology product manufacturers, lawmakers, large retailers, medical companies and research and development agencies to make informed decisions about synthetic biology products manufacturing, designing marketing, growth strategies and gaining competitive advantage.
Browse Blogs : Medicalcare And Pharmaceutical Market News
Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. TMR exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers.
TMR’s experienced team of analysts, researchers, and consultants use
proprietary data sources along with various tools and techniques to gather and
analyze information. TMR business offerings represent the latest and
the most reliable information which is indispensable for businesses to sustain
their competitive edge.
TMR data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
• TMR esearch reports cover global markets, present analysis and forecast for a period of five years.
• The market structure and forecasts are developed on the basis of secondary research and are cross-validated through primaries conducted with industry players and key opinion leaders (KOLs).
• Respondents are led through a questionnaire to gather quantitative and qualitative inputs on their operations, performance, strategies and views on the overall market, including key developments and technology trends.
• Data from interviews are then consolidated, checked for consistency and accuracy, and inserted into the Transparency Market Research data model to arrive at the market numbers following the bottom–up approach.
90 State Street,
Albany ,NY ,United States - 12207